Companies
Explore all the available companies. Are you wondering how to find wonderful businesses at great price? Start from A... or take a look at Compoundeer Ranking.
Protagenic Therapeutics, Inc.new
Protagenic Therapeutics, Inc. (NASDAQ:PTIX) is a biopharmaceutical company focused on developing innovative peptide-based therapeutics targeting the biological pathways underlying stress-related neurological and mood disorders. The company's lead compound, PT00114, is a synthetic analog of a naturally occurring brain peptide that helps regulate the body's stress response and emotional equilibrium.
PTIXProtagonist Therapeutics, Inc
Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company. Two novel peptides derived from Protagonist's proprietary discovery platform are currently in advanced Phase 3 clinical development, with a New Drug Application (NDA) for icotrokinra submitted to the FDA in July, and an NDA for rusfertide submitted in December 2025. Icotrokinra (formerly, JNJ-2113), is a first-in-class investigational targeted oral peptide that selectively blocks the Interleukin-23 receptor ("IL-23R"), which is licensed to Janssen Biotech, Inc., a Johnson & Johnson company. Following icotrokinra's joint discovery by Protagonist and Johnson & Johnson scientists pursuant to the companies' IL-23R collaboration, Protagonist was primarily responsible for the development of icotrokinra through Phase 1, with Johnson & Johnson assuming responsibility for development in Phase 2 and beyond.
PTGXProtalix Biotherapeutics, Inc.
Protalix is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx®. Protalix was the first company to gain U.S. Food and Drug Administration (FDA) approval of a protein produced through plant cell-based in suspension expression system. Protalix's unique expression system represents a new method for developing recombinant proteins in an industrial-scale manner. Protalix's first product manufactured by ProCellEx, taliglucerase alfa, was approved by the FDA in May 2012 and, subsequently, by the regulatory authorities of other countries. Protalix has licensed to Pfizer Inc. the worldwide development and commercialization rights for taliglucerase alfa, excluding Brazil, where Protalix retains full rights.
PLXProtara Therapeutics, Inc.
Protara is a clinical-stage biotechnology company committed to advancing transformative therapies for people with cancer and rare diseases. Protara's portfolio includes its lead candidate, TARA-002, an investigational cell-based therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs). The Company is evaluating TARA-002 in an ongoing Phase 2 trial in NMIBC patients with carcinoma in situ (CIS) who are unresponsive or naïve to treatment with Bacillus Calmette-Guérin, as well as a Phase 2 trial in pediatric patients with LMs. Additionally, Protara is developing IV Choline Chloride, an investigational phospholipid substrate replacement for patients on parenteral nutrition who are otherwise unable to meet their choline needs via oral or enteral routes. For more information, visit www.protaratx.com.
TARAProtector Forsikring
Protector Forsikring ASA provides a wide range of insurance products to companies and public organizations, primarily in Norway, Sweden, and Denmark. Protector's products include workers' compensation, group life, accident, health, property, motor, liability, cargo, and change of ownership insurance. Insurance premiums provide nearly all of the company's revenue. Protector's commercial business provides insurance for more than 5,000 companies, most of which have annual insurance premiums between NOK 100,000 and NOK 3 million. The public business provides coverage to more than 500 municipalities and 30 countries.
PSKRFProthena Corp Public Ltd Co
Prothena Corporation plc is a late-stage clinical biotechnology company with expertise in protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare peripheral amyloid diseases. Fueled by its deep scientific expertise built over decades of research, Prothena is advancing a pipeline of therapeutic candidates for a number of indications and novel targets for which its ability to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins can be leveraged. Prothena's pipeline includes both wholly-owned and partnered programs being developed for the potential treatment of diseases including ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Parkinson's disease and a number of other neurodegenerative diseases.
PRTAProto Labs Inc
Protolabs is the world's fastest manufacturing service enabling companies across every industry to streamline production of quality parts throughout the entire product life cycle. From custom prototyping to end-use production, we support product developers, engineers, and supply chain teams along every phase of their manufacturing journey.
PRLBProtokinetix, Inc.
ProtoKinetix Inc is a research and development stage biotechnology company focused on scientific medical research of AFGPs (Anti-Freeze Glycoproteins). The AFGP is a compound produced by fish, insects, reptiles, bacteria, and plants that enable survival in freezing temperatures. The company also develops AFGP applications which include regenerative medicine issues including harvesting, processing, storage and transplanting cells, tissues and organs and treatments for chronic inflammatory conditions and diseases caused by stress factors, including UV radiation, oxidation, and cryopreservation and hydrogen peroxide.
PKTXProvectus Biopharmaceuticals, Inc.
Provectus Biopharmaceuticals, Inc. is a clinical-stage biotechnology company developing a pipeline of immunotherapy medicines based on rose bengal sodium, a first-in-class synthetic small molecule from the halogenated xanthene family. The Company's clinical programs span oncology, dermatology, and ophthalmology, with additional proof-of-concept programs in hematology, wound healing, infectious diseases, and tissue repair.
PVCTProvident Financial Holdings Inc
Provident Financial Holdings Inc is engaged in providing community and mortgage banking services to consumers and small to mid-sized businesses in the Inland Empire region of Southern California. The company's business segment is Bank. The Bank's activities include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. It offers business checking accounts, other business banking services and services loans for others.
PROVProvident Financial Services Inc
Provident Financial Services, Inc. is the holding company for Provident Bank, a community-oriented bank offering "Commitment you can count on" since 1839. Provident Bank provides a comprehensive array of financial products and services through its network of branches throughout New Jersey, Bucks, Lehigh and Northampton counties in Pennsylvania, as well as Orange, Queens and Nassau Counties in New York. The Bank also provides fiduciary and wealth management services through its wholly owned subsidiary, Beacon Trust Company and insurance services through its wholly owned subsidiary, Provident Protection Plus, Inc.
PFSPrudential Financial Inc
Prudential Financial, Inc. (NYSE: PRU), a global financial services leader and premier active global investment manager with approximately $1.6 trillion in assets under management as of Sept. 30, 2025, has operations in the United States, Asia, Europe, and Latin America. Prudential's diverse and talented employees help make lives better and create financial opportunity for more people by expanding access to investing, insurance, and retirement security. Prudential's iconic Rock symbol has stood for strength, stability, expertise, and innovation for 150 years.
PRUPrudential Plc
Prudential is an Asia and Africa health and life insurance business and is focused on long-term savings. The business is increasingly focusing on digital offerings and creating strong brand equity and relationships with customers of its products through these.
PUKPrysmian S.p.a.
Prysmian SpA is an Italian manufacturer of electric power transmission and telecommunications cables and systems. Its business is organized in three segments--Projects, which focuses on the execution of underground and submarine cable projects; Energy Products, which provides power distribution, and industrial and network components; and Telecom, which makes cable systems and connectivity products. More than half of the firm's revenue is generated in the Europe, Middle East, and Africa regions, with the rest coming from North America, Latin America, and Asia-Pacific regions.
PRYMFPs International Group Ltd.
PS International Group Ltd, formerly PSI Group Holdings Ltd is a freight forwarding service provider in Hong Kong with networks across the globe. It provides air and ocean export and import freight forwarding services with optional ancillary logistics-related services such as cargo pick up, cargo handling at ports and local transportation and warehousing-related services such as repackaging, labelling, palletization, preparation of shipping documentation, arrangement of customs clearance and warehousing to meet the requirement of customers.
PSIGPsq Holdings, Inc.
PublicSquare (NYSE: PSQH) is a financial technology company building a resilient, values-aligned ecosystem of financial solutions for consumers and businesses. Committed to protecting life, family, and liberty, the Company provides alternatives designed to support long-term economic participation and freedom.
PSQHPsyched Wellness Ltd.
Psyched Wellness Ltd. is a Canadian-based health supplements company dedicated to researching and producing consumer packaged goods products derived from our proprietary extract of the Amanita Muscaria mushroom, AME-1.
PSYCFPsychemedics Corp
Psychemedics NASDAQ: PMD is the worlds leading drug testing company using hair for the detection of drugs of abuse. Psychemedics has been successfully operating for 30 years and thousands of corporations worldwide currently rely on Psychemedics patented hair analysis technology for their pre-employment and employee drug screening. Psychemedicsu200b clients include over 10% of the Fortune 500 some of the largest police departments in America Federal Reserve Banks and schools.
PMDIPsyence Biomedical Ltd.
Psyence Biomedical Ltd. (Nasdaq: PBM) is one of the few multi-asset, vertically integrated biopharmaceutical companies specializing in psychedelic-based therapeutics. It is the first life sciences biotechnology company focused on developing nature-derived (non-synthetic) psilocybin and ibogaine-based psychedelic medicine to be listed on Nasdaq. We are dedicated to addressing unmet mental health needs. We are committed to an evidence-based approach in developing safe, effective, and FDA-approved nature-derived psychedelic treatments for a broad range of mental health disorders.
PBMPt Ace Hardware Indonesia, Tbk.
No description
PHDWYPt Bank Negara Indonesia (persero) Tbk
PT Bank Negara Indonesia (Persero) Tbk is an Indonesian state-owned bank, with the government holding just over half of the bank's outstanding shares. BNI's main banking activities include deposit-taking, providing credit, issuing debt instruments, money transfer services, secondary market services, wholesale banking, custody banking, capital investment, and other services. Its business divisions include Corporate and International Banking; Institutional Banking; Enterprises and Commercial Banking; Consumer Banking and Treasury.
PBNNFPt Barito Renewables Energy Tbk
No description
PBRRYPt Bukalapak.com Tbk
PT Bukalapak.com Tbk is a trusted online shopping site in Indonesia that sells a variety of products that are needed by Indonesian people. It offers electronic, cosmetic, apparel and various other products.
BKLPFPt Chandra Asri Petrochemical Tbk
PT Chandra Asri Petrochemical Tbk produces petrochemicals. Its products are olefins, polyolefins, styrene monomer, butadiene, and its byproducts. The company operates through Olefin; Polyolefin; Styrene monomer; Butadiene; Methyl Tertiary Butyl Ether (MTBE) and Butene-1 and Tanks and jetty rental. It generates maximum revenue from the polyolefins segment. The Polyolefins segment comprises the manufacturing of polyethylene and polypropylene petrochemicals.
PTCAYPt Dayamitra Telekomunikasi Tbk
No description
PDYTYPt Goto Gojek Tokopedia Tbk
No description
GGTKYPt Medco Energi Internasional Tbk
PT Medco Energi Internasional Tbk, together with its subsidiaries, explores for and produces oil and gas in Indonesia, Asia, Africa, the Middle East, the United States of America, and Europe. It operates through Exploration and Production of Oil and Gas, Services, Power, Chemicals, and Trading segments. The company operates production, development, and exploration blocks in the Riau Islands, South Sumatra, Central Sulawesi, Aceh, East Java, and Kalimantan in Indonesia, and holds oil and gas assets in Thailand, Oman, Yemen, Mexico, and Tanzania. It also operates drilling and workover rigs, and gas pipelines, and provides support services for oil and gas activities, and security services. In addition, the company is involved in copper and gold mining operations in Sumbawa, Nusa Tenggara, and production and trade of chemicals.
MDCOYPt Sumber Alfaria Trijaya Tbk
No description
PSBTYPt Xlsmart Telecom Sejahtera Tbk
PT XL Axiata TBK is a telecommunications company. The company generates revenue from the provision of mobile services. Within mobile services, the products offered are SMS, data, and voice, with data and voice comprising the bulk of overall company revenue. The majority of PT XL Axiata's subscriber base is on the 2G spectrum. Additionally, it is an owner of the telecommunications infrastructure, specifically mobile base stations and fiber networks. It also derives revenue from renting out the telecommunication towers. The company generates the vast majority of its revenue in Indonesia.
PTXKYPtc Inc.
PTC (NASDAQ: PTC) is a global software company that enables manufacturers and product companies to digitally transform how they design, manufacture, and service the physical products that the world relies on. Headquartered in Boston, Massachusetts, PTC employs over 7,000 people and supports more than 30,000 customers globally.
PTC
